Epidemiological features of hepatitis B and C infection in a high risk population: results of screening programs
- PMID: 24834260
- PMCID: PMC4017516
Epidemiological features of hepatitis B and C infection in a high risk population: results of screening programs
Abstract
Aim: The aim of this study was to report the epidemiological features of HBV & HCV infection in an Iranian high risk population.
Background: Hepatitis B and hepatitis C infections are worldwide serious public health problems. Iran has an intermediate prevalence of infection and a screening program was started in 2010 among high risk individuals.
Patients and methods: This cross-sectional study was conducted on 4455 new patients during two past years. Demographic information, age, gender, occupational status, medical history, history of vaccination against HBV, high risk exposure and laboratory findings were collected for each patient. Then distribution of demographic and risk factors was evaluated in each type of hepatitis.
Results: The mean age of patients was 45.6±17.3 years. More than two-thirds of the diagnosed cases were infected with HBV. 74% of patients were carriers of hepatitis virus. 60% of patients had no symptoms at diagnosis. Illicit intravenous drug use was most common high risk exposure in patients under study (n=366, 8.2%). High risk behaviors including illicit intravenous drug use and unprotected sex were relatively higher in patients infected with hepatitis C compared to patients with hepatitis B infection.
Conclusion: Findings of this study suggest that illicit intravenous drug use, contact with an infected household member and unprotected sex are the most common high risk exposure in Iranian patients infected with viral hepatitis. Therefore, preventive strategies such as health education, vaccination and screening programs should be directed to these groups. The results also show that a majority of patients have no symptoms at the time of diagnosis, therefore periodic screening tests in high risk groups is required.
Keywords: Epidemiology; Hepatitis B; Hepatitis C; Risk factor.
Similar articles
-
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.Int J Drug Policy. 2019 Nov;73:129-134. doi: 10.1016/j.drugpo.2019.09.018. Epub 2019 Oct 22. Int J Drug Policy. 2019. PMID: 31654935
-
Association of Routine Hepatitis B Vaccination and Other Effective Factors with Hepatitis B Virus Infection: 25 Years Since the Introduction of National Hepatitis B Vaccination in Iran.Iran J Med Sci. 2021 Mar;46(2):93-102. doi: 10.30476/ijms.2019.83112.1199. Iran J Med Sci. 2021. PMID: 33753953 Free PMC article.
-
Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.BMC Public Health. 2013 Jan 18;13:50. doi: 10.1186/1471-2458-13-50. BMC Public Health. 2013. PMID: 23331910 Free PMC article.
-
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5. Adv Parasitol. 2016. PMID: 27015949 Review.
-
[Evaluation of viral hepatitis in solid organ transplantation].Acta Med Croatica. 2014 Apr;68(2):151-9. Acta Med Croatica. 2014. PMID: 26012153 Review. Croatian.
Cited by
-
How much does vaccination reduce the rate of HBV infection in Iranian population? a Bayesian adjustment analysis.Gastroenterol Hepatol Bed Bench. 2019;12(Suppl1):S136-S144. Gastroenterol Hepatol Bed Bench. 2019. PMID: 32099614 Free PMC article.
-
Hepatitis B virus infection among sexually active individuals in Nigeria: a cross-sectional study.Pan Afr Med J. 2018 Jun 20;30:155. doi: 10.11604/pamj.2018.30.155.14886. eCollection 2018. Pan Afr Med J. 2018. PMID: 30455784 Free PMC article.
-
Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy.World J Hepatol. 2015 Apr 18;7(5):761-8. doi: 10.4254/wjh.v7.i5.761. World J Hepatol. 2015. PMID: 25914776 Free PMC article. Review.
-
Evaluation of single nucleotide polymorphism in interleukin 22 (IL-22) gene and its association with chronic hepatitis B infection.Gastroenterol Hepatol Bed Bench. 2019 Fall;12(4):309-314. Gastroenterol Hepatol Bed Bench. 2019. PMID: 31749919 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous